Woodhead Publishing Bioinspired and Biomimetic Materials for Drug Delivery (Woodhead Publishing Series in Biomaterials)

Bioinspired and Biomimetic Materials for Drug Delivery delves into the potential of bioinspired materials in drug delivery, detailing each material type and its latest developments. In the last decade, biomimetic and bioinspired materials and technology has garnered increased attention in drug delivery research. Various material types including polymer, small molecular, protein, peptide, cholesterol, polysaccharide, nano-crystal and hybrid materials are widely considered in drug delivery research. However, biomimetic and bioinspired materials and technology have shown promising results for use in therapeutics, due to their high biocompatibility and reduced immunogenicity. Such materials include dopamine, extracellular exosome, bile acids, ionic liquids, and red blood cell. This book covers each of these materials in detail, reviewing their potential and usage in drug delivery. As such, this book will be a great source of information for biomaterials scientists, biomedical engineers and those working in pharmaceutical research. Review Explores the potential and usage of bioinspired materials for drug delivery applications About the Author Dr. Md Nurunnabi is an Assistant Professor of Pharmaceutical Sciences in the School of Pharmacy and Adjunct faculty in Biomedical Engineering and Environmental Science & Engineering at the University of Texas at El Paso. Over the past decade, he received training in biomaterials, nanotechnology, and drug delivery. He received Bachelor in Pharmacy from UODA, and MS and PhD in Bioengineering and from the Korea National University of Transportation. Prior to starting his postdoctoral training at Harvard University in 2016, he has completed a short postdoctoral training at the Chungnam National University. In addition to his academic research, he has been involved in industrial research. He was co-founder and chief scientist at the KB BioMed Inc. (Currently Scientific Advisory Board), and an Associate Scientist in Chunbo Corporation Ltd, in South Korea. Dr. Nurunnabi has published over 50 peer-reviewed papers and edited two books and holds 10 issued/pending patents. Currently, he serves on the editorial advisory board of ACS Biomaterials Science & Engineering since and as Vice Chair of Controlled Release Society’s Bioinspired and Biomimetic Delivery focus group. He served as Secretary of Postdoc Association at Harvard Medical School (2016-2017) and President of Postdoc Association Massachusetts General Hospital (2017-2018) among various leadership roles.